bioMerieux Executive and Leadership Team

Sofiann Krati, the Chief Financial Officer at bioMerieux, directs global financial strategy and operations. This leadership role involves managing all aspects of the company's financial health, including budgeting, forecasting, and financial reporting. Krati ensures robust financial controls are in place to support bioMerieux's mission of developing innovative in vitro diagnostics. Overseeing capital allocation, Krati drives investment in research and development to maintain the company's competitive edge in detecting infectious diseases and other critical health conditions. The Chief Financial Officer's oversight extends to optimizing financial performance across all business units, ensuring sustainable growth and profitability. Sofiann Krati's financial acumen underpins the company's ability to deliver essential diagnostic tools to clinical laboratories and healthcare professionals worldwide, directly impacting patient care and outcomes.

Evren Fırat, the Chief Financial Officer Türkiye at bioMerieux, manages the financial operations and strategic planning for the Turkish market. This role involves overseeing all financial activities, including budgeting, financial analysis, and reporting, tailored to the specific economic landscape of Türkiye. Fırat ensures compliance with local financial regulations while aligning with bioMerieux's global financial objectives. The Chief Financial Officer Türkiye plays a crucial part in supporting the company's expansion and market penetration within the region, facilitating the delivery of innovative in vitro diagnostic solutions. Evren Fırat's financial leadership contributes to the sustained growth of bioMerieux's presence in Türkiye, enabling healthcare professionals and laboratories to access advanced tools for disease detection and health monitoring.

Jana Inman, the Chief Financial Officer, Global Research & Development at bioMerieux, directs financial strategy and resource allocation for the company's extensive research and development initiatives. This critical position involves managing budgets for groundbreaking projects focused on detecting infectious diseases, cancer, and other health conditions. Inman ensures that R&D investments are optimized to drive innovation in in vitro diagnostics, supporting the development of new instruments, reagents, and software. The Chief Financial Officer, Global Research & Development collaborates closely with scientific teams to facilitate the translation of research discoveries into market-ready solutions. Jana Inman's financial oversight is paramount to bioMerieux's commitment to advancing scientific understanding and delivering cutting-edge diagnostic tools to clinical laboratories and healthcare providers globally.

Juney Barros, the Vice President, Chief Financial Officer Latin America at bioMerieux, leads financial strategy and management for the Latin American region. This executive oversees all financial operations, including budgeting, forecasting, and financial analysis, to support bioMerieux's growth objectives in diverse Latin American markets. Barros ensures financial compliance with regional regulations and optimizes resource allocation for key business initiatives. The Vice President, Chief Financial Officer Latin America plays a pivotal role in expanding access to innovative in vitro diagnostics, supporting healthcare professionals and clinical laboratories in their efforts to detect diseases. Juney Barros's financial leadership strengthens bioMerieux's position in Latin America, driving the company's mission to improve global health through advanced diagnostic solutions.

Yew Tan, the Chief Financial Officer, Asean at bioMerieux, directs financial strategy and operations for the Association of Southeast Asian Nations region. This executive manages all financial aspects, including budgeting, financial planning, and performance analysis, to support bioMerieux's objectives in this dynamic market. Tan ensures adherence to local financial regulations and optimizes financial resources for regional growth initiatives. The Chief Financial Officer, Asean is critical in facilitating the deployment of innovative in vitro diagnostic solutions, empowering healthcare providers and laboratories to enhance disease detection capabilities. Yew Tan's financial acumen strengthens bioMerieux's market position across the Asean region, contributing to the company's global mission of advancing health through diagnostics.

Pedro Soares, the Head Chief Financial Officer, Finance Brasil at bioMerieux, oversees the financial operations and strategic financial planning for bioMerieux's activities in Brazil. This role involves managing budgets, financial reporting, and ensuring fiscal compliance within the Brazilian market. Soares supports the company's objectives by optimizing financial performance and resource allocation for key business initiatives. The Head Chief Financial Officer, Finance Brasil plays a vital part in enabling the delivery of innovative in vitro diagnostic solutions to Brazilian healthcare professionals and laboratories. Pedro Soares's financial expertise contributes to bioMerieux's sustained growth and operational effectiveness within Brazil, furthering the company's mission to improve global health.

Gabriel Jauncey, the Chief Operating Officer at bioMerieux, executes the company's operational strategy to support its global in vitro diagnostics business. This executive directs the day-to-day management of all operational functions, ensuring efficiency and quality in the development, manufacturing, and distribution of instruments, reagents, and software. Jauncey's responsibilities include optimizing supply chain logistics and production processes to meet the demands of clinical laboratories and healthcare professionals worldwide. The Chief Operating Officer ensures seamless integration of new technologies and services, aligning operational capabilities with bioMerieux's commitment to combating infectious diseases and other health conditions. Gabriel Jauncey's leadership drives operational excellence, enabling the company to deliver critical diagnostic solutions that improve patient care and public health outcomes across diverse markets.

Jessica Weidner, the Clinical Operations, Chief of Staff (North America) at bioMerieux, enhances the efficiency and strategic execution of clinical operations across the North American region. This role involves coordinating key initiatives, managing cross-functional projects, and ensuring alignment between clinical laboratory needs and bioMerieux's diagnostic solutions. Weidner supports the strategic deployment of instruments, reagents, and services that aid in the detection of infectious diseases and other health conditions. The Clinical Operations, Chief of Staff (North America) facilitates communication and collaboration between clinical teams and leadership, driving operational excellence. Jessica Weidner's contributions are vital to strengthening bioMerieux's market presence and impact in North America, ensuring healthcare professionals have access to essential diagnostic technologies.

Clemencia Bolívar, the Chief Of Staff - LATAM at bioMerieux, drives strategic initiatives and operational alignment across the Latin American region. This role involves coordinating key projects, facilitating communication between departments, and ensuring the effective implementation of bioMerieux's business objectives. Bolívar supports the expansion of in vitro diagnostic solutions, enabling healthcare professionals and laboratories to better detect infectious diseases and other health conditions. The Chief Of Staff - LATAM works closely with regional leadership to enhance operational efficiency and market responsiveness. Clemencia Bolívar's strategic support is instrumental in strengthening bioMerieux's presence and impact throughout Latin America, advancing the company's mission to improve global health outcomes.

Charles Cooper, the Executive VP & Chief Marketing Officer at bioMerieux, leads global marketing strategies and brand development for the company's in vitro diagnostics portfolio. This executive directs all marketing functions, including market research, product positioning, and promotional campaigns, to drive demand for bioMerieux's instruments, reagents, and software. Cooper ensures that marketing efforts effectively communicate the value of diagnostic solutions for detecting infectious diseases, cancer, and other health conditions to clinical laboratories and healthcare professionals worldwide. The Executive VP & Chief Marketing Officer collaborates with sales and R&D teams to align market insights with product innovation. Charles Cooper's strategic marketing leadership is essential for expanding bioMerieux's global reach and reinforcing its position as a leader in diagnostic innovation.